The present invention relates to 1-arylsulfonyl-3-substituted indole or indoline derivatives having the general formula I
wherein the dotted line represents an optional bond; n is 0 or 1; m is 0-5 and Ar, R
6
-R
11
, are defined in the description. The invention further relates to pharmaceutical compositions comprising said derivatives, and to the use of these 1-arylsulfonyl-3-substituted indole or indoline derivatives in the treatment of central nervous disorders such as psychosis, schizophrenia, manic depressions, depressions, neurological disorders, cognitive enhancement, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's disease.
本发明涉及具有一般式I的1-芳基磺酰基-3-取代
吲哚或
吲哚啉衍
生物,其中虚线表示可选键;n为0或1;m为0-5,而Ar、R6-R11在说明中定义。本发明还涉及包含所述衍
生物的制药组合物,并且涉及使用这些1-芳基磺酰基-3-取代
吲哚或
吲哚啉衍
生物治疗中枢神经系统疾病,如精神病、精神分裂症、躁郁症、抑郁症、神经系统疾病、认知增强、帕
金森病、肌萎缩性侧索硬化症、阿尔茨海默病和亨廷顿病。